Grand Vista Biotechnology
Grand Vista Biotechnology is a biotechnology company that develops clinical projects for immune and stem cell therapy.
Industries
analytics
biotechnology
test-and-measurement
Nr. of Employees
small (1-50)
Grand Vista Biotechnology
Sugar Land, Texas, United States, North America
Products
USCAR-T 5th Generation Technology
A non-viral method for CAR-T cell therapy that reduces costs and treatment time, enhances T cell function, and targets solid tumors by deactivating immune inhibitory genes.
Universal Chimeric Antigen Receptor T-Cell (CAR-T)
A therapy targeting leukemia and multiple myeloma using CD19, CD20, and BCMA antigens.
Strengthened Chimeric Antigen Receptor T-Cell (CAR-T)
A therapy for colon cancer and brain tumors using chimeric CEA CAR, PD1 knockout, and GD2 CAR with PD1 knockout.
Alipocyte of Early Differentiation Stage
A dermal injection of early-stage adipose tissue for skin regeneration and hair growth promotion.
USCAR-T 5th Generation Technology
A non-viral method for CAR-T cell therapy that reduces costs and treatment time, enhances T cell function, and targets solid tumors by deactivating immune inhibitory genes.
Universal Chimeric Antigen Receptor T-Cell (CAR-T)
A therapy targeting leukemia and multiple myeloma using CD19, CD20, and BCMA antigens.
Strengthened Chimeric Antigen Receptor T-Cell (CAR-T)
A therapy for colon cancer and brain tumors using chimeric CEA CAR, PD1 knockout, and GD2 CAR with PD1 knockout.
Alipocyte of Early Differentiation Stage
A dermal injection of early-stage adipose tissue for skin regeneration and hair growth promotion.